A novel dual PARP-HDAC inhibitor for treatment of Ewing sarcoma. (October 2022) - Truong, S.; Zhai, B.; Ghaidi, F.; Ramos, L.; Joshi, J.; Brown, D.; Sankar, N.; Langlands, J.; Bacha, J.; Shen, W.; Sorensen, P.; Daugaard, M.